Cell-based Therapy for Hypertension: Challenges and Perspectives

被引:1
|
作者
Gasparotto Junior, Arquimedes [1 ]
dos Reis Livero, Francislaine Aparecida [2 ]
机构
[1] Fed Univ Grande Dourados, Fac Hlth Sci, Lab Electrophysiol & Cardiovasc Pharmacol, Rodovia Dourados Itahum,Km 12,POB 533, BR-79804970 Dourados, MS, Brazil
[2] Univ Paranaense, Lab Preclin Res Nat Prod, Umuarama, PR, Brazil
关键词
Chronic non-communicable disease; hypertension; stem-cell therapy; unconventional treatment; herbal medicines; antibodies; PULMONARY ARTERIAL-HYPERTENSION; PLURIPOTENT STEM-CELLS; ENDOTHELIAL PROGENITOR CELLS; ACUTE MYOCARDIAL-INFARCTION; MARROW MONONUCLEAR-CELLS; ISCHEMIC-HEART-DISEASE; EXTRACELLULAR VESICLES; BLOOD-PRESSURE; IN-VITRO; CARDIAC DIFFERENTIATION;
D O I
10.2174/1381612824666180903142858
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Hypertension is a non-transmissible chronic disease with a high prevalence, morbidity, and mortality. Different strategies for the treatment of hypertension are employed worldwide, but the control of hypertension remains a major challenge for global health. Many unsuccessful unconventional therapies have been proposed in recent years, including herbal medicines and the development of small molecules or antibodies that seek to disrupt the disease's pathogenesis. Cell-based therapies may be used as replacement or complementary treatment strategies. The results of recent preclinical studies of cell-based therapies are promising. However, human clinical trials are scarce, the data are insipid, and many issues have been raised about the safety and efficacy of cell-based therapies. The present review summarizes research on cell-based therapy for hypertension. We also briefly summarize relevant clinical trials and discuss future perspectives and possible clinical applications.
引用
收藏
页码:3084 / 3089
页数:6
相关论文
共 50 条
  • [21] Challenges and Prospects for Stem Cell-Based Therapy in Diabetes Mellitus
    Assady, Suheir
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2009, 11 (04): : 212 - 215
  • [22] Current Perspectives Regarding Stem Cell-based Therapy for Ischemic Stroke
    Kwak, Kyeong-Ah
    Kwon, Ho-Beom
    Lee, Joo Won
    Park, Young-Seok
    CURRENT PHARMACEUTICAL DESIGN, 2018, 24 (28) : 3332 - 3340
  • [23] Current Perspectives Regarding Stem Cell-Based Therapy for Liver Cirrhosis
    Kwak, Kyeong-Ah
    Cho, Hyun-Jae
    Yang, Jin-Young
    Park, Young-Seok
    CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 2018
  • [24] Cell-Based Therapy for Urethral Regeneration: A Narrative Review and Future Perspectives
    Jin, Yangwang
    Zhao, Weixin
    Yang, Ming
    Fang, Wenzhuo
    Gao, Guo
    Wang, Ying
    Fu, Qiang
    BIOMEDICINES, 2023, 11 (09)
  • [25] Cell-Based Prostacyclin Gene Therapy Prevents Pulmonary Arterial Hypertension
    Zhou, Lei
    Cheng, Zhiqiang
    Vanderslice, Peter
    So, Shuiping
    Ruan, Kehe
    Willerson, James T.
    Dixon, Richard A.
    CIRCULATION, 2011, 124 (21)
  • [26] Opportunities and Challenges: Stem Cell-Based Therapy for the Treatment of Ischemic Stroke
    Tang, Yao-Hui
    Ma, Yuan-Yuan
    Zhang, Zhi-Jun
    Wang, Yong-Ting
    Yang, Guo-Yuan
    CNS NEUROSCIENCE & THERAPEUTICS, 2015, 21 (04) : 337 - 347
  • [27] Endothelial progenitor cells in pulmonary hypertension - dawn of cell-based therapy?
    Toshner, M.
    Morrell, N. W.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2010, 64 : 7 - 12
  • [28] Challenges for Mesenchymal Stem Cell-Based Therapy for COVID-19
    Li, Chenghai
    Zhao, Hua
    Wang, Bin
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2020, 14 : 3995 - 4001
  • [29] Challenges Facing Airway Epithelial Cell-Based Therapy for Cystic Fibrosis
    Berical, Andrew
    Lee, Rhianna E.
    Randell, Scott H.
    Hawkins, Finn
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [30] Mesenchymal Stem Cell-Based Therapy for Cardiovascular Disease: Progress and Challenges
    Bagno, Luiza
    Hatzistergos, Konstantinos E.
    Balkan, Wayne
    Hare, Joshua M.
    MOLECULAR THERAPY, 2018, 26 (07) : 1610 - 1623